Antigenics ANTI Stock
0 USD
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
OTC Markets EXMKT
Market Cap
0 USD
LOW - HIGH [24H]
0.0000
-
0.0000 USD
VOLUME [24H]
3K USD
{{ volume }}
P/E Ratio
0
Earnings per share
0 USD
Antigenics Price Chart
Antigenics ANTI Financial and Trading Overview
Antigenics stock price | 0.0000 USD |
Previous Close | 7.0E-6 USD |
Open | 1.0E-6 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 1.0E-6 - 1.0E-6 USD |
52 Week Range | 1.0E-6 - 0.0001 USD |
Volume | 31K USD |
Avg. Volume | 0 USD |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ANTI Valuation Measures
Enterprise Value | N/A |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
Antigenics Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 0.0001 USD |
52 Week Low | 1.0E-6 USD |
50-Day Moving Average | 1.0E-5 USD |
200-Day Moving Average | 2.71E-5 USD |
ANTI Share Statistics
Avg. Volume (3 month) | 0 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | N/A |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | N/A |
Most Recent Quarter (mrq) | N/A |
Next Fiscal Year End | N/A |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | N/A |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of Antigenics
Country | United States |
State | PA |
City | Huntingdon Valley |
Address | 1850 Terwood Road |
ZIP | 19006-5518 |
Phone | N/A |
Website | https://agenusbio.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Antigenics, Inc. is based in Huntingdon Valley, Pennsylvania.
Q&A For Antigenics Stock
What is a current ANTI stock price?
Antigenics ANTI stock price today per share is 0.0000 USD.
How to purchase Antigenics stock?
You can buy ANTI shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Antigenics?
The stock symbol or ticker of Antigenics is ANTI.
Which industry does the Antigenics company belong to?
The Antigenics industry is Biotechnology.
How many shares does Antigenics have in circulation?
The max supply of Antigenics shares is 0.
What is Antigenics Price to Earnings Ratio (PE Ratio)?
Antigenics PE Ratio is now.
What was Antigenics earnings per share over the trailing 12 months (TTM)?
Antigenics EPS is 0 USD over the trailing 12 months.
Which sector does the Antigenics company belong to?
The Antigenics sector is Healthcare.